Deep Reinforcement Learning for Clinical Decision Support: A Brief
  Survey by Liu, Siqi et al.
1–24
Deep Reinforcement Learning for Clinical Decision Support:
A Brief Survey
Siqi Liu E0272316@u.nus.edu
NUS Graduate School for Integrative Sciences and Engineering
National University of Singapore
21 Lower Kent Ridge Rd, Singapore 119077
Kee Yuan Ngiam kee_yuan_ngiam@nuhs.edu.sg
Department of General Surgery
National University Hospital
5 Lower Kent Ridge Rd, Singapore 119074
Mengling Feng ephfm@nus.edu.sg
Saw Swee Hock School of Public Health
National University of Singapore
12 Science Drive 2, Singapore 117549
Abstract
Owe to the recent advancements in Artificial Intelligence especially deep learning, many
data-driven decision support systems have been implemented to facilitate medical doctors
in delivering personalized care. We focus on the deep reinforcement learning (DRL) models
in this paper. DRL models have demonstrated human-level or even superior performance in
the tasks of computer vision and game playings, such as Go and Atari game. However, the
adoption of deep reinforcement learning techniques in clinical decision optimization is still
rare. We here present the first survey that summarizes reinforcement learning algorithms
with Deep Neural Networks (DNN) on clinical decision support. We also discuss some case
studies, where different DRL algorithms were applied to address various clinical challenges.
We further compare and contrast the advantages and limitations of various DRL algorithms
and present a preliminary guide on how to choose the appropriate DRL algorithm for
particular clinical applications.
1. Introduction
The effective combination of deep learning (deep neural networks) and reinforcement learning
technique, named Deep Reinforcement Learning (DRL), is initially invented for intelligent
game playing(Mnih et al., 2013; Silver et al., 2016) and has later emerged as an effective
method to solve complicated control problems with large-scale, high-dimensional state and
action spaces(Mnih et al., 2015). The great applications of deep reinforcement learning to
these domains have relied on the knowledge of the underlying processes (e.g., the rules of
the game).
In the healthcare domain, the clinical process is very dynamic. The ’rules’ for making
clinical decisions are usually unclear(Marik, 2015). For instance, let us consider the following
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DRL Survey for Clinical Decision Support
clinical decision-making questions: will the patient benefit from the organ transplant; under
what condition the transplant will become a better option; what are the best medications
and dosages to prescribe after the transplantation. The decisions from those questions should
dedicate to the individual patient’s condition. In order to find the optimal decisions to those
questions, conducting randomized clinical trials (RCTs) are usually the choice. However,
RCTs can be unpractical and infeasible in certain clinical conditions. Therefore, starting
from analyzing the observational data becomes an alternative. With the improvement of
data collection and advancement in DRL technologies, we see great potentials in DRL-based
decision support system to optimize treatment recommendations.
Technical Significance This survey paper summarizes and discusses major types of DRL
algorithms that have been applied to clinical applications to provide clinical decision support.
Furthermore, we discuss the trade-offs and assumptions for these DRL algorithms. This
paper aims to serve as a guideline to assist our audience to pick the appropriate DRL
models for their particular clinical applications. To the best of our knowledge, this is the
first survey paper on DRL for treatment recommendation or clinical decision support.
Clinical Relevance DRL is proven to achieve the human-level capacity for learning com-
plex sequential decisions in specific domains, such as video game, board game, and au-
tonomous control. While in healthcare, DRL has not been widely applied for clinical ap-
plications yet. In this paper, we survey major DRL algorithms that provide sequential
decision support in the clinical domain. We believe that learning from the vast amount of
collected electronic health record (EHR) data, DRL is capable of extracting and summa-
rizing the knowledge and experience needed to optimize the treatments for new patients.
DRL also has the potential to expand our understanding of the current clinical system by
automatically exploring various treatment options and estimate their possible outcomes.
Structure This paper surveys the reported cases on the applications of DRL algorithms
for clinical decision support. In part 2, we first introduce the basic concepts of RL and DRL.
Then we summarize the main types of DRL algorithms. In part 3, we present a few clinical
applications that use various DRL algorithms. In part 4, we discuss how to choose among
various DRL algorithms. Finally, in part 5, we investigate the challenges and the remedies
of using DRL for clinical decision support.
2. Fundamentals of Reinforcement Learning
Reinforcement learning (RL)(Sutton et al., 1998) is a goal-oriented learning tool wherein an
agent or a decision maker learns a policy to optimize a long-term reward by interacting with
the environment. At each step, an RL agent gets evaluative feedback about the performance
of its action, allowing it to improve the performance of subsequent actions(Kiumarsi et al.,
2018). Mathematically, this sequential decision-making process is called the Markov Decision
Process (MDP)(Howard, 1960).
2
DRL Survey for Clinical Decision Support
2.1. MDP Formulation
A Markov decision process is defined by 4 major components:
• A state space S: at each time t, the environment is in state st ∈ S
• An action space A: at each time t, the agent takes action at ∈ A, which influence the
next state, st+1
• A transition function P (st+1 |st, at): the probability of the next state given the current
state and action, which represent an environment for the agent to interact.
• A reward function r(st, at) ∈ R: the observed feedback given the state-action pair
(st, at).
In a clinical context, we consider an agent as a clinician. We can think the state as the
wellbeing/condition of a patient. The state of the patients can depend on his demographics
(e.g., age, gender, ethnicity, etc.), longitudinal and physiological measurements (e.g., lab
test, vital signs, medical image reports, etc.) and some other clinical features. An action
is a treatment that clinicians act to the patient (e.g., prescription of certain medication,
ordering of surgical procedures, etc.). The transition function P (st+1 | st, at) can be view as
the patient’s own biological system, that given the current wellbeing and the intervention,
the patient will enter the next time step st+1. If the wellbeing is improved, we assign a
reward to the agent, and we penalize the agent if the patient’s condition gets worse or stay
stagnant after the intervention.
The objective of the reinforcement learning agent(Sutton and Barto, 2018) is defined as
the expected total reward along with a trajectory τ that follow the distribution p(τ), i.e., a
mapping from state to action pi(a | s), that maximizes the expected accumulated reward.
pi∗ = argmaxEτ∼p(τ)[
∑
t
γtr(st, at)]︸ ︷︷ ︸
J
(1)
where p(τ) is the probability distribution over state-action trajectories, and γ is a discounted
factor.
The expected long term reward noted as J in equation (1), is the objective that we want
to maximize w.r.t. a policy pi(a | s). The optimal policy pi∗ is the one that maximizes the
objective J .
To evaluate how ’good or bad’ a state or an action is, we define Q-function and value-
function in equation (2) and (3) respectively.
Qpi(st, at) =
T∑
t′=t
Epi[r(st′ , at′) | st, at] (2)
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V pi(st) = Eat∼pi(at,st)[Q
pi(st, at)] (3)
Q-function Qpi(st, at) is the conditional expectation of cumulative reward given the cur-
rent state-action pair (st, at), whereas the value V pi(st) is the expectation of Q-value at
(st, at) and take action at according to the policy pi.
If we know the actual Q-function or value-function for all possible states and actions in
an environment, an optimal policy pi∗ will be easy to derive from equation (1). An agent at
each state st will pick an action if it maximizes the Q-function or the value-function.
2.2. Deep Reinforcement Learning
Deep Reinforcement Learning (DRL) adopts deep neural networks (DNN)(Cireşan et al.,
2012) to replace tabular representations for Q(st, at), V (st) or pi in traditional RL. For com-
plex environments with a large number of states, tabular representations are not feasible
due to the large-scale storage and high computation requirements (Curse of Dimensionality).
Different DRL algorithms use DNN in various ways. For instance, in policy gradient
RL(Sutton et al., 2000), DNN can be used to optimize a policy pi(θ), where θ is the param-
eters (weights) in DNN. The input to the DNN is the current state, and the output is an
action. By taking the gradient of DNN, at each time step, the parameters θ in the DNN are
updated and thus the policy is improved.
In value-based RL(Kaelbling et al., 1996), DNN can be used to approximate the value
function or the Q-function. For the value function, DNN take the current state (st) as the
input and the output is the approximated value Vˆ pi(st) given a policy pi. whereas for Q-
function approximation, DNN take the state-action pair (st, at) as the input and output is
the Qˆφ(st, at) value, where φ is the parameter in DNN for value-based RL. In model-based
RL(Doya et al., 2002), DNN is used to approximate the transition function pφ(st+1 | st, at).
We will discuss the architecture for different DRL in details in section 2.4. In order to
have a clearer understanding of DRL, let us first discuss the key steps in RL algorithms, then
we will introduce main types of RL algorithms, including policy gradient RL, valued-based
RL, actor-critic RL(Grondman et al., 2012), model-based RL and some other extensions of
RL algorithms. (From this point onward, all the RL algorithms we discuss in this paper refer
to RL with DNN architecture (DRL). We will use the term ’RL’ and ’DRL’ interchangeably,
while they both refer to Deep RL.)
2.3. Key Steps in Reinforcement Learning
Most RL algorithms can be broken down into 3 steps:
Step 1. Sample collection
Step 2. Evaluate objective
Step 3. Improve policy
4
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We take policy gradient RL as an example. In step 1, the RL algorithm interacts with
the environment and generate sample (state-action pairs) by following an unlearned policy
(The initialization can be random). The set of state-action pairs are sequential and form
a trajectory τ . The RL algorithm can generate multiple trajectories in step 1. In the next
step, the RL algorithm will try to evaluate how good or bad are those collected trajecto-
ries by calculating the objective function J (cumulative reward). Then in step 3, the RL
algorithm will try to maximize the objective J by increasing the chance of visiting those
highly rewarded trajectories and reducing the chance of visiting low rewarded trajectories,
and this is called policy update. The agent will then go back to step 1 to generate new
samples according to the update policy and will repeat step 2 and 3 to update the policy.
In this way, the policy is improved over time by ’trial and error’.
Most RL algorithm follows this three-step structure, but the three steps are not equally
important in different RL algorithms. So, which RL algorithm works the best for an applica-
tion is a context-dependent question. We will discuss this question in more details in section
4. For now, let us go through the cost in the three steps briefly. In step 1, if we collect data
samples from a real physical system, then data generation would be expensive because the
data collection is in real time. In contrast, if we use simulators to generate samples, like
those in Atari games(Mnih et al., 2013), then samples are much easier to obtain and step 1
would probably not be a concern in this case.
For step 2, if the application uses policy gradient to improve policy, where the policy can
be improved by trial and error, then the objective J will be the sum of a few rewards from
those trials. However, for model-based RL, if the model is fitted using DNN, then fitting
the model will be expensive that we need to make sure the fitted model converges and close
to the actual model.
In step 3, policy gradient RL will only require us to compute the gradient and apply the
gradient to the policy. It is still relatively simple. However, for model-based RL with DNN,
we will need to do the backpropagation for a vast number of time steps to improve the policy.
When it comes to real-world applications, especially in clinical applications, data gener-
ation is often a big concern because it is in real time, and many of the observational data
(from Electronic Health Records) are private that we do not readily have access. We also
do not wish to estimate values by trials and error, because it is often unethical and costly.
Therefore, when we choose the RL algorithms, we need to be aware of those constraints.
In this paper, we will first focus on discussing the main types of RL algorithms that
were applied for clinical decision support, while only briefly cover one RL algorithm which
is rarely applied in clinical applications. We will also discuss the underlying reason why
specific algorithms are not so "popular" compared to others in the healthcare domain.
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2.4. Types of Reinforcement Learning Algorithms
Policy Gradient Reinforcement Learning Under section 2.3, we discussed the three-
step structure of general RL algorithm. Policy Gradient RL follows this three-step structure.
In step 1, the policy gradient RL first rolls out a random policy pi(θ) to the environment
and generate trajectories under the policy. The environment is the transition function that
does not need to specify in this setting. Because we are not interested to learn the exact
transition function in policy gradient RL. After a few trials, we collect a set of trajectories,
and we come to step 2 to evaluate the reward J(θ). It can be approximated by samples from
trajectories that are collected in step 1. J(θ) ≈ 1N
∑
i
∑
t
r(si,t, ai,t) In step 3, we’ll apply
gradient to the expected long term reward J(θ) and update the policy piθ, where new θ′ is set
to θ + α∇θJ(θ).Then we need to sample new state-action pairs from the updated policy θ′
in step 1 and do the optimization of policy step by step. We call this on-policy(Krstic et al.,
1995), because every time the policy changes, we need to sample new data under the new
policy. In contrast to on-policy, off-policy applies when we can improve the policy without
generating new samples from the policy. Therefore, policy gradient RL is an on-policy RL
algorithm.
In policy gradient RL, DNN is used to construct a policy in step 3, where the input to
the DNN is state and output is an action. Figure 1 is the MDP diagram of policy gradient
RL. By taking a gradient of J(θ) and update the weights in DNN, the policy is learned
accordingly. In the clinical context, policy gradient RL is not as ’popular’ compared to
other RL algorithms. The underlying reason for this may lie on the fact that it is an on-
policy algorithm that needs to collect data iteratively based on a new policy. The algorithm
is learned by ’trial and error.’ Most clinical applications cannot afford the cost of collecting
real-time clinical data. For instance, to learn the optimal clinical decisions of medication
dosage for sepsis patients, it would be unethical to do trial and error and will also be time-
consuming. However, policy gradient RL is still popular under other domains, such as robot
control and computer board game, where the environment is a simulator that can afford for
the trial and error.
Value-based Reinforcement Learning Value-based RL tries to estimate the value func-
tion or Q-function for certain state and action. The Q-function in equation (2) is also known
as bellman equation. Value-based RL tries to evaluate either value function V pi(st) or Q-
function Qpi(st, at) from the conditional cumulative reward using DNN in step 2. While
for value function, the input to the DNN is state st, and output is V pi(st); For Q-function,
the input to the DNN is state-action pair (st, at), and output is Qpi(st, at). The DNN is
trained to optimize the Mean Squared Error (MSE) given as L(φ) = 12
∥∥∥Vˆ piφ (st)− yt+1∥∥∥2,
where yt+1 is called target value. yt+1 = max
at+1
γQpi(st+1, at+1) for value function and
yt+1 = r(st, at) + γmax
at+1
Qpi(st+1, at+1) for Q-function. This optimization can be done with
various Gradient Descent methods in deep learning, such as Stochastic Gradient Descent
(SGD)(Bottou, 2010). So DNN is implemented in step 2 of the RL algorithm since it’s
evaluating the objective J(θ) that is estimated by Q-function or value function. In step 3,
value-based RL update the policy pi to pi′ only if the action taken from pi′ resulted in the
6
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Figure 1: MDP for policy gradient RL algorithm
maximum for Q-function.
pi′(at, st) =
{
1, if at = argmaxat Qpi(st, at),
0, otherwise
(4)
These two algorithms are called Fitted Value Iteration (FVI)(Munos and Szepesvári,
2008) and Fitted Q Iteration (FQI)(Riedmiller, 2005) respectively. A special case for
FQI is called Q-learning(Watkins and Dayan, 1992), wherein step 1 we only take one tuple
of sample (st, at, st+1, rt) and use that for Q-function approximation. Wewe use one gradient
step to do parameter update, then go back to step 1 to collect one more tuple of the new
sample and do the optimization iteratively. The term ’Q-learning’ also sometimes refers to
general value-based RL in some literature.(Arulkumaran et al., 2017)
FVI, FQI, and Q-learning work well for off-policy samples and do not have a high-
variance as in policy gradient RL(Arulkumaran et al., 2017). However, the limitation is
that they often not converge for non-linear function approximation (such as DNN). Besides,
the samples collected from Q-learning are temporal sequential; thus samples are highly cor-
related(Arulkumaran et al., 2017). Then the network might only find the optimal local
solution. Another issue with Q-learning is that its target value yt+1 is estimated using one
tuple sample and iterate over multiple one-step estimations. It makes the target value very
unstable.
Lin (1992) mitigated the problem of highly correlated samples using a new component
named ’replay buffer’ with Q-learning. Q-learning with replay buffer sample a batch
of tuples (st, at, st+1, rt) and use the batch to do a one-step gradient for parameter update
and go back to the buffer to collect another batch of tuples. In this way, samples are no
longer correlated, and multiple samples in the batch also ensure low gradient variance. To
7
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mitigate the problem of the unstable target value, ’target network’ is introduced by Mnih
et al. (2016), where the target value yt+1 is estimated by a fixed value and only gets updated
after a few iterations of learning. Combining the two components, ’replay buffer’ and ’target
network’ with Q-learning, Mnih et al. (2015) defined a new RL algorithmDeep Q-Network
(DQN).
However, DQN is also not perfect. It has the same limitation as Q-learning that it
often overestimate Q-function (Thrun and Schwartz, 1993). The overestimation is due to
’max’ term in the estimated target value function yt+1 = r(st, at) + γmax
at+1
Qpi(st+1, at+1),
which is affected by noise during data collection(van Hasselt, 2011). One possible method to
mitigate this issue is to use Double Q-Learning (Double DQN) where (Hasselt, 2010)
implemented two DNNs to learn two Q-functions. They used one of them to evaluate the
Q-value and let the other one choose the action. The goal of having two Q-functions is to
de-correlate the noise in both action and Q-function.
Value-based RL is commonly applied in clinical applications, and we will see more ex-
amples from section 3 Clinical applications on DRL.
Actor-Critic Reinforcement Learning Actor-critic RL(Heess et al., 2015) is a combi-
nation of policy gradient RL and value-based RL. In step 1, we sample state-action pairs
from policy just like those on the policy gradient RL, but this time, the state-action pairs
are generated by a DNN (actor) that act according to the policy piθ. Then, in step 2, we
fit the value Vˆ piφ (st) =
∑T
i=tEpiθ [r(si, ai) | st] to sampled reward sums using another DNN
(critic), the input to DNN is state s, and the output is Vˆ pi(s). We evaluate a new term
named ’advantage’(Baird III, 1993; Harmon and Baird III, 1996) Aˆpi(si, ai), which is defined
as Aˆpi(si, ai) = r(si, ai) + Vˆ piφ (s
′)− Vˆ piφ (s). where Vˆ piφ (s′) is the estimated value for the next
state s′. Advantage function tells us how much better is that action than the average action
in the state according to the estimated value function. Then in step 3, we take the gradi-
ent of the cumulative advantage Aˆpi(si, ai) along the trajectory and update θ in the actor
DNN to learn a better policy. The critic DNN can be optimized by supervised regression,
L(φ) = 12
∥∥∥Vˆ piφ (st)− yt∥∥∥2, where yt can be estimated by either Monte Carlo estimation of
reward along the trajectory, or it can be estimated by bootstrap method. The Actor-critic
RL is an off-policy algorithm, but an alternative version can also be an on-policy algorithm.
The only difference is in step 1, instead of collecting a batch of trajectories, we only collect
one trajectory and update the policy to generate new samples from the updated policy.
Again, the on-policy will not be suitable to implement in real-time clinical applications;
thus one of the applications discussed in this paper(Wang et al., 2018) utilized the off-policy
actor-critic RL algorithm.
Model-based Reinforcement Learning All the above discussed RL algorithms are all
model-free RL, and in model-free RL we assume we do not know about the exact transi-
tion function p(st+1 | st, at). So given the current state and action pair, we do not know
what the real next state is. The model-free RL does not attempt to learn the transition
function explicitly but bypass it by sampling from the environment. Knowing the right tran-
sition function or the environment will always be helpful. Moreover, in certain situations,
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we do know about the transition function, such as a simple board game where we design
the rules ourselves. For clinical applications, most of the time we are not sure about the
exact transition function, but we do know a bit about the dynamics of the environment.
For instance, clinicians generally know that after treating a sick patient with appropriate
medication dosage, the patient will gradually recover from a sick state to a healthy state.
Even if we do not know the full picture of the environment, we can still propose several
models to estimate the real transition function (environment) and optimize it from there.
It is called model-based RL(Doya et al., 2002). There are various models we can use to
estimate the transition function, such as Gaussian process(GP)(Deisenroth and Rasmussen,
2011; Rasmussen, 2003), DNN, Gaussian mixture models (GMM)(Chernova and Veloso,
2007), and so on. With DNN model-based RL, the input to the DNN is state-action pair
(st, at) and output is st+1. The DNN is implemented in step 2 for the transition function.
In contrast to DNN as the model for the environment, GP is very data efficient. GP can
produce reasonably decent predictions of the next state using few data samples. It is useful
in the clinical context since most of the clinical application suffers from the data deficiency
problem. However, the limitation for GP is that it has troubles when the actual transition
function is non-smooth. Moreover, GP can be slow if the number of samples is vast and
in high dimensional space. It is the opposite of DNN, wherein DNN larger the number of
samples, the more accurate prediction in general. So in clinical context when the input state
is medical images (very high dimensional), DNN will be more suitable for model-based RL
than GP.
Other Extensions of Reinforcement Learning
• Hierarchical Reinforcement Learning
When the learning task is massive, and we have seen several different state-action
spaces in RL with several sub-optimal policies, it is intuitive to sequence the sub-
space and try to obtain the optimal policy for global space. Hierarchical RL(Kulkarni
et al., 2016) generally contains a two-level structure. The lower level is just like the
policies we trained in general RL algorithms that try to suggest an action given (st, at).
In the same time, there exists a higher level network where the ’meta-policy’ trains
to select which of these lower level policies to apply over a trajectory. Hierarchical
RL has the advantage of learning faster global optimal policy compared to policies
randomly initiated, and it transfers the knowledge learned from past tasks from lower
level policies. In the clinical setting, the state-action space can be huge due to the
complex behavior of human interactions. Therefore, applying the Hierarchical RL is a
very natural choice for clinical applications. However, the architecture for Hierarchical
RL is more complicated to train, and inappropriate transfer learning can result in
’negative transfer’(Pan and Yang, 2010) where the final policy is not necessarily better
than lower level policies.
• Recurrent Reinforcement Learning
A fundamental limiting assumption of Markov decision processes is the Markov prop-
erty (full observation of MDP), which is rarely satisfied in real-world problems. In
9
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medical applications, it is unlikely that a patientâĂŹs full clinical state will be mea-
sured. It is known as a Partially Observable Markov Decision Process (POMDP)
problem(Kaelbling et al., 1998). A POMDP has a 4-tuple (S,A,R,O), where O are
observations. Classic DQN is only useful if the observations reflect the underlying
state.(Hausknecht and Stone, 2015). Hausknecht and Stone (2015) proposed an ex-
tension to DQN network to deal with POMDP problem, where the first fully con-
nected layer of DQN is replaced with Long Short Term Memory (LSTM)(Hochreiter
and Schmidhuber, 1997). This new RL algorithm is called Deep Recurrent Q-Network
(DRQN)(Hausknecht and Stone, 2015). Their algorithm showed that it could integrate
information successfully through time and could replicate DQNâĂŹs performance on
standard Atari games with a setting of POMDP for the game screen.
• Inverse Reinforcement Learning
To learn most of the standard RL algorithm in clinical applications, we would design
the reward function by hand, but we do not know what the real reward is. This reward
design is very vulnerable to if it is misspecified. Inverse RL is an algorithm that we
can infer the correct reward function from expert demonstrations without having to
program the reward by hand.(Ghavamzadeh et al., 2015; Abbeel and Ng, 2004; Ng
et al., 2000) Alternative to Inverse RL is to learn them directly from the behaviors
from experts, and this often refers to imitation learning(Schaal, 1999). However, one
limitation for imitation learning is that the experts may have different capabilities and
prone to be imperfect(Wang et al., 2018); learning from experts may only result in
sub-optimal policies. So generally in Inverse RL, we are given state-action space and a
sub-optimal policy in a dynamic model. The goal of Inverse RL is to recover the right
reward function. Then we can use the learned reward function to get a new policy
which is better than the sub-optimal policies. The reward can be learned by DNN
where the input is state-action pairs (s, a) produced by a sub-optimal policy pi#, then
the output of the DNN is a reward rΦ(s, a), where Φ is the parameters to the DNN
that we would learn through backpropagation. Later after we obtained rΦ(s, a), we
can use the new reward function to plan for better policy and hopefully the optimal
policy pi∗. In the clinical context, it is important to reason about what the clinicians
are trying to achieve and what they think is essential.
3. Deep Reinforcement Learning for Clinical Applications
Recent research(Prasad et al., 2017; Nemati et al., 2016; Tseng et al., 2017) have demon-
strated that DRL can be used to provide treatment recommendation and clinical decision
support for various applications with different types of data sources, ranging from EHR,
online disease database, and genetic data, and so on. The applications include medica-
tion/fluid choice, dosage for patients with acute or chronic disease, settings and duration of
mechanical ventilation, and constructing clinical motifs from clinical notes. Table 1 sum-
marizes all the clinical application papers discussed in this survey, in particular highlighting
the distinct sub-type of DRL methods and different clinical problems. As discussed in the
earlier section, the policy gradient RL is an on-line algorithm that does not fit with most clin-
10
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ical applications. Therefore, value-based RL algorithms were popular in clinical applications.
For each application in this section, we will investigate what RL algorithms the author
used, the formulation of context-based MDP (S,A,R), and finally the performance of the
RL. We first discuss the applications that used value-based RL, followed by actor-critic
RL, model-based RL, hierarchical RL, recurrent RL and finally inverse RL. For value-based
RL, we further divide the application based on the sub-types of value-based RL algorithms,
which contain Fitted Q Iteration, DQN, and double DQN.
3.1. Value-based Reinforcement Learning
Fitted Q Iteration
Weaning of Mechanical Ventilation
Weaning patients in the intensive care unit from mechanical ventilation (MV) is often
haphazard and inefficient. With this regard, Prasad et al. (2017) used an off-policy Fitted
Q Iteration (FQI) algorithms to determine ICU strategies for the MV administration, they
aimed to develop a decision support tool that could leverage available patient information in
the data-rich ICU setting to alert clinicians when a patient was ready for initiation of wean-
ing, and to recommend a personalized treatment protocol. They used MIMIC-III database
to extract 8860 admissions from 8182 unique adult patients undergoing invasive ventilation
for more than 24 hours.
They included features like patients’ demographic characteristics, pre-existing conditions,
co-morbidities and time-varying vital signs. They preprocessed the lab measurements and
vitals using Gaussian Process (GP) to impute missing values; this could ensure more precise
policy estimation. The state st was a 32-dimensional feature vector. The action was de-
signed as a 2-dimensional vector with the 1st dimension of on/off MV and the 2nd dimension
for four different levels of dosage for sedation. Reward rt with each state encompassed both
time-into-ventilation and physiological stability, whereas reward would increase with stable
vitals and successful extubation, but would penalize on adverse events (reintubation) and
additional ventilator hour. Comparing to the actual policy implemented at the Hospital of
University of Pennsylvania, HUP, their learned policy matched 85% of actual policy.
Optimal Heparin Dosing in ICU
Mismanagement of certain drugs can drive up costs by unnecessarily extending hospital
length of stay, and place patients at risk. Unfractionated Heparin(UH) is one example of such
drugs that overdosing leads to increased risk of bleeding and underdosing leads to increased
risk of clot formation. RL is particularly well-suited for the medication dosing problem given
the sequential nature of clinical treatment. Nemati et al. (2016) trained an RL medication
dosing agent to learn a dosing policy that maximized the overall fraction of time given pa-
tient stays within his/her therapeutic activated partial thromboplastin time (aPTT). They
used the MIMIC-II database and extracted 4470 patients who received an intravenous hep-
arin infusion at some point during their ICU stay with a time window of 48 hours. Variables
11
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included demographics, lab measurements and severity scores(Glasgow Coma Score(GCS),
daily Sequential Organ Failure Assessment(SOFA)score). A state was constructed using the
features and estimated by discriminative hidden Markov model (DHMM)(Kapadia, 1998).
Whereas the discrete action was using discretized heparin values from six quantile intervals,
and the reward was designed according to the aPPT feedback. Given the feedback, a de-
cision was made to increase, decrease or maintain the heparin dosage until the next aPTT
measure. rt = 21+e−(aPTTt−60) − 21+e−(aPTTt−100) − 1. This function assigned a maximal re-
ward of one when a patient’s aPTT value was within the therapeutic window which rapidly
diminished towards a minimal reward of -1 as the distance from the therapeutic window
increases.
The performance of the optimal policy was tested by comparing the accumulated reward
from a clinician and the trained RL agent. On average and consistently over time, the RL
algorithm resulted in the best long-term performance by following the recommendations of
the agent.
Deep Q Network
Extract Clinical Concepts from Free Clinical Text
Extracting relevant clinical concepts from a free clinical text is a critical first step for
diagnosis inference. Ling et al. (2017) proposed to use DQN to learns clinical concepts from
external evidence (Wikipedia: Signs and Symptoms Section and MayoClinic: Symptoms
section). They used TREC CDS dataset(Simpson et al., 2014) to conducted their experi-
ments. This dataset contains 30 topics, where each topic is a medical free-text that described
a patient’s situation with a diagnosis. MetaMap(Aronson, 2006) extracted clinical concepts
from TREC CD5 and external articles. The state contained two vectors: current clinical
concepts, as well as candidate concepts from external articles: the more similar between the
two vectors, the higher state value, would be. The action space was discrete that included
action to accept or reject candidate concepts. The reward was designed in a way such that it
was high when candidate concepts were more relevant than current concepts for a patient’s
diagnosis. DQN was trained to optimize the reward function that measured the accuracy of
the candidate clinical concepts. Their preliminary experiments on the TREC CDS dataset
demonstrated the effectiveness of DQN over various non-reinforcement learning based base-
lines.
Symptom Checking 1.0
To facilitate self-diagnosis, Tang et al. (2016) proposed symptom checking systems. A
symptom checker first asked a sequence of questions regarding the condition of a patient.
Patients would then provide a sequence of answers according to the questions. Then the
symptom checker tried to make a diagnosis based on the Q&A. Tang et al. proposed an RL
based ensemble model to train this symptom checker. They implemented 11 DQN models,
while each model represented an anatomical part of a human body, such as head, neck, arm,
etc. Those model were trained independently of each other. For each anatomical model, the
state s was one-hot encoded based on a symptom. (i.e., if the symptom were a headache,
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then only the anatomical model representing head would have s = 1, while other models
would have s = 0). The action was discrete and had two types: inquiry and diagnosis. If
the maximum Q-value corresponded to the action of inquiry, the symptom checker would
continue to ask the next question. If the maximum Q-value corresponded to the action of
diagnosis. The symptom checker would give a diagnosis and terminate. The reward was
designed as a scalar. The agent would receive the reward when it could correctly predict
the disease with a limited number of inquiries. They applied the DQN algorithms on a
simulated disease dataset, and the result showed that symptom checker could imitate the
behavior of inquiry and diagnosis as those performed by doctors.
Double DQN
Sepsis Treatment 1.0
Raghu et al. (2017). was one of the first ones to directly discuss the application of DRL
to healthcare problems. They used the Sepsis subset of the MIMIC-III dataset and chose to
define the action space as consisting of Vasopressors and IV fluid. They grouped drugs doses
into four bins consisting of varying amounts of each drug. Q-values were frequently over-
estimated in practice, leading to incorrect predictions and poor policies. Thus the authors
solved this problem with a Double DQN(Wang et al., 2015). They also employed dueling
deep Q Network to separate value and advantage streams, where the value represented the
quality of the current state, and the advantage represented the quality of the chosen action.
The reward function was clinically motivated based on the SOFA score which measures
organ failure. They demonstrated that using continuous state space modeling, the found
policies could reduce patient mortality in the hospital by 1.8% to 3.6%.
3.2. Actor-critic Reinforcement Learning
Optimal medical prescription in ICU
Wang et al. (2018) adopted the Actor-critic RL algorithms to find optimal medical pre-
scriptions to patients with various diseases. They experimented with MIMIC-III database
and extracted 22,865 admissions. Features used for state construction included demo-
graphics, vitals, lab results, etc. Action space was 180 distinct ATC codes. Wang et
al. not just implemented classic actor-critic RL. Instead, they combined both RL with
Supervised learning (SL) in the actor-network. The objective function J(θ) was evalu-
ated as the linear combination of objective function for both RL and SL in the equation:
J(θ) = (1− )JRL(θ) + (−JSL(θ)), where  was a hyperparameters that ranges from 0 to 1,
and it used to balance the RL and SL. JRL(θ) was objective in actor-network, while JSL(θ)
was evaluated as the cross-entropy loss between the predicted treatment and prescriptions
given by the doctor.
They applied gradient ascent to the objective function w.r.t. θ in the actor-network, and
tried different  value for RL-SL balancing. Besides, they also incorporated an LSTM net-
work to improve performance in the partial observed MDP (POMDP). The state s was
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replaced by summarizing the entire historical observations with ct = f(o1, o2, . . . , ot) and ct
was used as state for both actor and critic networks. Their experiments showed that the
proposed network could detect good medication treatment automatically.
3.3. Model-based Reinforcement Learning
Radiation dose fraction for lung cancer
Tseng et al. (2017) implemented model-based RL to train a dose escalation policy for
patients received radiotherapy with lung cancer. They included 114 patients in the RL de-
sign and first trained a DNN to estimate the transition function p(st+1 | st, at). The loss
function for the DNN model aimed to minimize the difference between the expectation of
Q-values from the estimated trajectory with the observed values. After the construction of
the transition function, Tseng et al. applied DQN to learn an optimal policy for the dose in
thoracic irradiation that trade-off between the local control (LC) and the risk for radiation-
induced pneumonitis (RP). The reward for the network was designed as a trade-off between
encouraging improved LC and attempting to suppress RP. State of DQN was defined as
a combination of 9 features, including cytokines, PET radiomics, and dose features. The
action was designed as the dose per fraction.
Since the construction of the transition function would require a large amount of data. The
authors implemented drop-off in the DNN in transition function to avoid overfitting. Be-
sides, the authors implemented a Generative Adversarial Networks (GAN)(Goodfellow et al.,
2014) to simulate more data to mitigate the data deficiency problem. The simulated data
from GAN was also fed to the transition function DNN to training. The proposed (Model-
based RL) network showed a promising result that it could suggest similar treatment dose
compared with clinicians.
3.4. Hierarchical Reinforcement Learning
Symptom Checking 2.0
The main idea from Kao et al. (2018)’s work was to imitate a group of doctors with
different expertise who jointly diagnose a patient. Since a patient could only accept an in-
quiry from one doctor at a time, a meta-policy was required to appoint doctors, in turn, to
inquire to the patient. The meta-policy came from a higher level network. At each step, the
meta-policy was responsible for appointing an anatomical-part model to perform a symptom
inquiry for a disease prediction.
In Kao et al’s paper, the first hierarchy level was a master agent M. The master M possesses
its action space AM and policy piM . In this level, the action space AM equaled P , the set of
anatomical parts. At step t, the master agent entered state st, and it picked an action aMt
from AM according to its policy piM . The second level of hierarchy consists of anatomical
models mp. If the master acted aM , the task would be delegated to the anatomical model
mp = maM . Once the model mp was selected, the actual action at ∈ A was then performed
according to the policy of mp, denoted as pimp .
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Based on this structure, Kao et al. trained an online symptom checkers on simulated data
from SymCAT symptom disease database for self-diagnosis of health-related ailments. It
was the improved version of Symptom Checking 1.0, where Kao et al. added another layer
of DQN on top of anatomical models in Symptom Checking 1.0 as a master agent. Both the
anatomical models and the master model applied DQN to pick the action that maximized
the Q-value. Their result showed that the proposed Hierarchical RL algorithm significantly
improved the accuracy of symptom checking over traditional systems.
3.5. Recurrent Reinforcement Learning
Sepsis Treatment 2.0
Futoma et al. (2018) proposed a new extension to DRQN architecture with a multi-output
Gaussian process to train an agent to learn the optimal treatment for sepsis patients. They
collected data from private database in the Duke University health system with 9,255 sepsis
patients and their 165 features (including demographics, longitudinal physiological variables,
medication, etc. ), and followed up in 30 days. Actions were discrete values consisting of 3
common treatment for sepsis patients: antibiotics, vasopressors, and IV fluids. The reward
was sparsely coded. The reward at every non-terminal time point was 0. A reward was
+10 at the end of a trajectory if the patient survives; and -10 if the patient dead. They
investigated the effect of replacing fully connected neural network layers with LSTM layers
in the DQN architecture. The optimized policy for sepsis treatment could reduce patient
mortality by as much as 8.2% from an overall baseline mortality rate of 13.3%.
3.6. Inverse Reinforcement Learning
Diabetes Treatment
In previous papers, the reward function was approximated by the heuristic. However,
the appropriateness of the reward function could not be validated. In recent studies on RL,
inverse RL has been proposed to estimate the reward function of experts from their behavior
data. There have been some papers that focus on Inverse RL(Ng et al., 2000; Abbeel and
Ng, 2004). However, to the best of our knowledge, there was not any paper that imple-
mented DNN based Inverse RL algorithm for clinical decision support. For non-DNN based
Inverse RL, Asoh et al. (2013) implemented an Inverse RL in the Bayesian framework and
used Markov chain Monte Carlo sampling(Ghavamzadeh et al., 2015) to learn the reward
function in a clinical context. They applied the Inverse RL to learn the reward function for
diabetic treatments with a uniform prior. The drug prescription data was private with the
University of Tokyo Hospital. The state was discrete and defined as the severity of diabetes
(’Normal’, ’Medium’, ’Severe’). They used MCMC-sampling and derived the reward for
the 3 states as r = (0.01, 0.98, 0.01). The reward showed ’medium’-level diabetes patients
have the highest value. It seemed to contradict with the current clinical understanding that
the reward should have the highest value for ’normal’-level diabetic patients. Asoh et al.
explained that 65% of diabetic patients from their database were already in the ’medium’
condition. Therefore, keeping the patients in the ’medium’ state might be the best effort
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from clinicians.
Despite very few clinical application implemented Inverse RL, we believe that inverse
RL is a valuable topic, and it will benefit the applications in the clinical context. We are
not only optimizing the policy by mimicking experts behavior, but we are also very keen
to train the policy such that it can automatically figure out what are the treatments that
clinicians think important.
4. How to Choose among Reinforcement Learning Algorithms
There is no unique answer to this question. Choice of RL algorithm will depend on the
actual application. Below is a list of trade-offs and assumptions to consider:
Sample efficiency: Sample efficiency refers to how many samples are required to make
the algorithm converge. If the algorithm is on-policy, such as policy gradient RL, then it
would take more samples. In contrast, value-based RL and model-based RL are off-policy
algorithms, so that fewer samples are required for training. Actor-critic RL algorithm is
in between value-based RL and policy gradient RL. Given different sample efficiency, it
does not mean we should always choose the one that requires fewer samples. For specific
applications where samples are easily generated (i.e., symptom checker 1.0 used simulator
to generate data), the wall-clock time for model training may be more important than the
number of samples required. In such cases, on-policy RL algorithms might be preferred
because they are generally faster to converge than off-policy RL algorithms.
Convergence: Policy gradient performs gradient ascent on the objective function, and
it is guaranteed for convergence. Value-based RL minimizes the "Bellman error" of fit,
but in the worst case, it is not guaranteed to converge to anything in the nonlinear cases.
Whereas for model-based RL algorithm, the model minimizes the error of fit and the model
is guaranteed to converge. However, a better model is not equivalent to better policy.
Episodic/infinite horizon: Episodic means the there is an end-point for a state-action
trajectory. For instance, in the disease symptom checker application, an agent continuously
searches for the symptom, an episode is over when the agent found the disease. Episodic
is often assumed by policy gradient methods and also assumed by some model-based RL
methods. Infinite horizon means there is no clear endpoint for a trajectory. The time step
for the trajectory can go to infinity, but there will be some point where the distribution of
the state action pairs remain stable and not changing anymore. We refer this as stationary
distribution. Most of the applications we discuss in this paper are episodic and have clear
end-points(i.e., mortality, diagnosis of disease). The episodic assumption is usually assumed
by pure policy gradient RL and some model-based RL algorithms. Whereas we observed
value-based RL algorithm also works decently with many clinical applications in this paper.
Fully observed/ partially observed MDP When the MDP is fully observed, all the
main RL algorithms can be applied. Whereas for partially observed MDP, one possible
solution is to use recurrent RL, such as LSTM based DRQN algorithm, to aggregate all
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historical observation as the belief state. In real time, most of the clinical applications are
POMDP; we are only able to represent a patient’s state by their physiological features. For
the methods working in POMDPs, the approach of maintaining a belief state is widely used
besides RNN. The belief state is the posterior distribution over latent state based on the
historical incomplete and noisy observations. McAllister and Rasmussen (2017) illustrated
a particular case where partial observability is due to additive Gaussian white noise on the
unobserved state. Then belief can be used to filter the noisy observations. Igl et al. (2018)
proposed a deep variational reinforcement learning (DVRL) algorithm that used a DNN to
directly output belief state from noisy observations. They showed their algorithm outper-
formed recurrent RL on inferring the actual belief state.
5. Challenges and Remedies
Learning from limited observational data
The applications of Deep RL in the clinical setting is very different from the case for the
Atari game, where one can repeat the game many many times and play out all possible
scenarios to allow the Deep RL agent to learn the optimal policy. In the clinical setting, the
Deep RL agent requires to learn from a limited set of data and intervention variations that
were collected. It is known as the POMDP problem. Therefore, for clinical applications,
the improved policy learned by the RL agent is often not the optimal policy. As discussed
in the last section, this problem can be addressed by using a recurrent structure such as
LSTM(Futoma et al., 2018) or by inferring and maintaining a belief state with DNN(Igl
et al., 2018).
Definition of state action, reward space for clinical applications
Finding appropriate representation of the state, action, and reward function is challenging
in the clinical context(Futoma et al., 2018). One needs to define the reward function to
balance the trade-offs between short-term improvement and long-term success. Take sepsis
patients in ICU as an example. Periodic improvements in blood pressure may not lead to
improvements in patients’ outcome. However, if we solely focus on patients’ outcome (sur-
vival or death) as the reward, this will result in a very long sequence of learning without any
feedbacks for the agent. While the good news is for some RL algorithms, such as Inverse
RL, we do not need to design the reward by hand. It can be approximated using DNN, and
we might even train a reward that is closer to the actual reward than hand-crafted reward.
Performance Benchmarking
In other domain, such as video games, the successful implementation of DQN on Atari game
has attracted the great interest of researches in this field Mnih et al. (2013). For instance,
DeepMind applied actor-critic RL for their video game ’StarCraft II’(Alghanem et al., 2018).
Microsoft developed an open source environment for researchers to test on their video game
’Malmo’(Johnson et al., 2016b). All these successful implementations now are serving as
the benchmarks for any new applications of RL in video games. However, in the health-
care domain, the benchmark is absent due to the lack of many successful applications. We
observed that the majority of the existing RL healthcare applications utilized the MIMIC
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EHR database Johnson et al. (2016a). Thus, we plan to build a set benchmark using the
MIMIC data for the application of Deep RL for clinical decision support in ICUs.
Exploration/ Exploitation
The fundamental dilemma for RL is exploration versus exploitation. If an agent knows to
take certain actions would result in good reward, how can the agent decide whether to at-
tempt new behaviors to discover ones with higher reward (Exploration) or continue to do
the best thing it knows so far (Exploitation). Exploitation means to do things we know will
yield the highest reward, whereas exploration means to do things we have not done before,
but in the hopes of getting an even higher reward. Exploration can be challenging in clinical
settings due to ethics and treatment safety considerations. One paradigm for exploration-
exploitation balancing is to use -greedy search to explore random action with a probability
of  ∈ [0, 1]. The higher the value of , the more ’open-minded’ an agent will be to explore
an arbitrary action. Alternatives for choosing exploration or exploitation include optimistic
exploration(Auer et al., 2002), Thompson sampling(Chapelle and Li, 2011) and information
gain(Mohamed and Rezende, 2015; Houthooft et al., 2016).
Data deficiency and Data Quality
Almost all deep learning models have the problem of data deficiency in healthcare applica-
tions. Though there exist available public database, the smaller medical institution often
lack sufficient data to fit a good deep learning model relying on their local database. Possible
solutions include using GAN based models to generate data from similar distribution(Tseng
et al., 2017), or use transfer learning(Haarnoja et al., 2017) to pre-train the DNN model
from larger datasets and later apply it to a smaller hospital/institutional clinical data.
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Table 1: Deep Reinforcement Learning Applications for Clinical Decision Support
Application Con-
text
Task/Treatment Method Data Reference
Weaning of Mechani-
cal Ventilation
On/Off Mechanical
Ventilation, Sedation
dosage
Fitted Q Iteration MIMIC III (Prasad
et al.,
2017)
Optimal Heparin
Dosing in ICU
Medication Dosage Fitted Q Iteration MIMIC II (Nemati
et al.,
2016)
Concept extraction
from Free Clinical
Text
Extract diagnoses
and clinical concept
DQN TREC CDS (Ling
et al.,
2017)
Symptom Checking
1.0
imitate behavior of
inquiry/diagnosis
DQN Simulated Data (Tang
et al.,
2016)
Symptom Checking
2.0
imitate behavior of
inquiry/diagnosis
Hierarchical RL SymCAT (Simu-
lated)
(Kao
et al.,
2018)
Sepsis Treatment 1.0 Vasopressors, IV
fluid
Double DQN MIMIC III (Raghu
et al.,
2017)
Sepsis Treatment 2.0 Vasopressors, IV
fluid , antibiotics
MPG+ DRQN Duke University
health system
(private)
(Futoma
et al.,
2018)
Optimal medical pre-
scription in ICU
Medication choice Actor-critic RLL MIMIC III (Wang
et al.,
2018)
Radiation dose frac-
tion for lung cancer
Chemotherapy, Med-
ication type and
dosage
Model-based RL CIBMTR registry (Tseng
et al.,
2017)
Diabetes Treatment Investigate reward
for patient’s state
Inverse RL (Non-DNN) University of
Tokuo Hospital
(private)
(Asoh
et al.,
2013)
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